Which hedge funds own CRBP? CORBUS PHARMACEUTICALS HLDGS, Q2 2026 13F holders
21 tracked hedge funds disclosed a position in CRBP (CORBUS PHARMACEUTICALS HLDGS) in their Q2 2026 13F filings, worth $69.7m in total. The largest holder by portfolio weight is Stonepine Capital Management, LLC at 3.0% of its book. 3 opened a new position this quarter: Jones Hill Capital LP, DAFNA Capital Management LLC, Y-Intercept (Hong Kong) Ltd. 9 exited: Armistice Capital, LLC, 683 Capital Management, LLC, Prelude Capital Management, LLC.
- 21
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 3
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $7.4m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $6.7m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $69.7m
- Combined value Sum of the holders' reported positions in the security.
- 1.7%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Armistice Capital, LLC | 0.1% | $3.4m |
| 683 Capital Management, LLC | 0.07% | $803k |
| Prelude Capital Management, LLC | 0.04% | $477k |
| Laurion Capital Management LP | 0.02% | $184k |
| Hudson Bay Capital Management LP | 0.0% | $278k |
| Balyasny Asset Management L.P. | 0.0% | $612k |
| Point72 Asset Management, L.P. | 0.0% | $482k |
| Qube Research & Technologies Ltd | 0.0% | $173k |
| D. E. Shaw & Co., Inc. | 0.0% | $249k |
Ownership over time
Who discovered CRBP first? Beta
| Exome Asset Management LLC | Q1 2024 | +1.6 pts |
| Perceptive Advisors LLC | Q2 2016 | +1.2 pts |
| DAFNA Capital Management LLC | Q2 2016 | +0.8 pts |
| Prosight Management, LP | Q1 2024 | +0.1 pts |
| Sio Capital Management, LLC | Q2 2024 | 0.0 pts |
| Ikarian Capital, LLC high conviction | Q1 2024 | −0.9 pts |
| Cormorant Asset Management, LP high conviction | Q4 2016 | −2.2 pts |
| Octagon Capital Advisors LP | Q1 2024 | −3.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.